277 related articles for article (PubMed ID: 31435820)
1. Ovarian stimulation for fertility preservation or family building in a cohort of transgender men.
Adeleye AJ; Cedars MI; Smith J; Mok-Lin E
J Assist Reprod Genet; 2019 Oct; 36(10):2155-2161. PubMed ID: 31435820
[TBL] [Abstract][Full Text] [Related]
2. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.
Amir H; Yaish I; Samara N; Hasson J; Groutz A; Azem F
J Assist Reprod Genet; 2020 Oct; 37(10):2463-2472. PubMed ID: 32719977
[TBL] [Abstract][Full Text] [Related]
3. Oocyte retrieval outcomes among adolescent transgender males.
Amir H; Oren A; Klochendler Frishman E; Sapir O; Shufaro Y; Segev Becker A; Azem F; Ben-Haroush A
J Assist Reprod Genet; 2020 Jul; 37(7):1737-1744. PubMed ID: 32430731
[TBL] [Abstract][Full Text] [Related]
4. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine.
Leung A; Sakkas D; Pang S; Thornton K; Resetkova N
Fertil Steril; 2019 Nov; 112(5):858-865. PubMed ID: 31594633
[TBL] [Abstract][Full Text] [Related]
5. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
[TBL] [Abstract][Full Text] [Related]
6. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
7. Oocyte cryopreservation for women with GATA2 deficiency.
Zolton JR; Parikh TP; Hickstein DD; Holland SM; Hill MJ; DeCherney AH; Wolff EF
J Assist Reprod Genet; 2018 Jul; 35(7):1201-1207. PubMed ID: 29532200
[TBL] [Abstract][Full Text] [Related]
8. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
[TBL] [Abstract][Full Text] [Related]
9. Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation.
Schon SB; Shapiro M; Gracia C; Senapati S
J Assist Reprod Genet; 2017 Sep; 34(9):1207-1215. PubMed ID: 28656539
[TBL] [Abstract][Full Text] [Related]
10. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
Talaulikar VS; Conway GS; Pimblett A; Davies MC
Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
[TBL] [Abstract][Full Text] [Related]
11. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
12. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
[TBL] [Abstract][Full Text] [Related]
13. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
14. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
15. Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissue.
Nikiforov D; Junping C; Cadenas J; Shukla V; Blanshard R; Pors SE; Kristensen SG; Macklon KT; Colmorn L; Ernst E; Bay-Bjørn AM; Ghezelayagh Z; Wakimoto Y; Grøndahl ML; Hoffmann E; Andersen CY
J Assist Reprod Genet; 2020 Apr; 37(4):891-904. PubMed ID: 32096110
[TBL] [Abstract][Full Text] [Related]
16. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
17. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
[TBL] [Abstract][Full Text] [Related]
18. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
19. Successful oocyte cryopreservation using letrozole as an adjunct to stimulation in a transgender adolescent after GnRH agonist suppression.
Martin CE; Lewis C; Omurtag K
Fertil Steril; 2021 Aug; 116(2):522-527. PubMed ID: 33795140
[TBL] [Abstract][Full Text] [Related]
20. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
